Avience Biomedicals IPO
Allotment Status
Registrar: Skyline Financial Services
Results usually go live on 23 Jun 2026
Avience Biomedicals IPO — Quick Analysis
Avience Biomedicals IPO is currently open for subscription until 22 Jun 2026. The issue price is set at ₹208 per share. The grey market premium (GMP) stands at ₹85 (40.9%), indicating strong demand and an expected listing premium. Current subscription: 43.79x.
Overview
Avience Biomedicals is a open for subscription SME IPO in India, raising ₹30.24 Cr, with shares offered around ₹208. While the issue is open, compare live GMP and subscription on this page with the price band before you apply via your bank's UPI ASBA flow. As an SME issue, expect a larger lot size and thinner post-listing liquidity than a typical Mainboard IPO.
GMP and subscription figures are unofficial market data, refreshed twice daily for active IPOs. Last updated 20 Jun 2026, 09:06 am IST. How we source data · Disclaimer
Strengths
- Subscribed 43.79x — strong demand.
- Positive GMP of ₹85 (+40.9%).
Risks
- Listing price can fall below issue price despite positive GMP.
- SME — higher lots, lower liquidity, more volatility.
- GMP is unofficial — not a confirmed listing outcome.
GMP analysis
GMP is ₹85 (+40.9%). Strong pre-listing premium — sentiment is bullish, but not guaranteed. Subscription at 43.79x — retail allotment odds may be low.
FAQ
Avience Biomedicals IPO questions
- What is Avience Biomedicals IPO price?
- ₹208 per share. Confirm in the RHP before applying.
- What is Avience Biomedicals IPO GMP?
- ₹85 (+40.9%). Unofficial — changes daily.
- When does Avience Biomedicals IPO close?
- 22 Jun 2026. Apply and approve UPI mandate before this date.
- When is Avience Biomedicals allotment?
- Expected around 23 Jun 2026. Check the registrar link on this page.